Correction to: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance (Cell Death & Disease, (2017), 8, 1, (e2569), 10.1038/cddis.2016.438);H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance

Cell Death and Disease

Volumn 8, Issue 1, 2017, Pages

  Peng, Fei ^a,b   Li, Ting Ting ^a,b   Wang, Kai Li ^a,b   Xiao, Guo Qing ^a   Wang, Ju Hong ^a   Zhao, Hai Dong ^a   Kang, Zhi Jie ^a,b   Fan, Wen Jun ^a,b   Zhu, Li Li ^a   Li, Mei ^a   Cui, Bai ^a,b   Zheng, Fei Meng ^a,b   Wang, Hong Jiang ^a   Lam, Eric W F ^c   Wang, Bo ^b   Xu, Jie ^a,b   Liu, Quentin ^a,b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA LET 7; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LIN28; UNCLASSIFIED DRUG; H19 LONG NON-CODING RNA; LIN28B PROTEIN, HUMAN; MIRNLET7 MICRORNA, HUMAN; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER STEM CELL; CARCINOGENESIS; CELL MIGRATION; CELL POPULATION; CLONOGENESIS; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR PROMOTION; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; RNA, LONG NONCODING; RNA-BINDING PROTEINS;

EID: 85025472534     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-024-06793-5     Document Type: Erratum

References (50)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Filipova A, Seifrtova M, Mokry J, Dvorak J, Rezacova M, Filip S et al. Breast cancer and cancer stem cells: a mini-review. Tumori 2014; 100: 363-369.
4. Gianni L, Baselga J, Eiermann W, Porta VG, Semiglazov V, Lluch A et al. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. J Clin Oncol 2009; 27: 2474-2481.
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012; 379: 432-444.
6. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
7. Geng SQ, Alexandrou AT, Li JJ. Breast cancer stem cells: Multiple capacities in tumor metastasis. Cancer Lett 2014; 349: 1-7.
8. Alejandro De Los A, Francesco F, Ruibin X, Yuko F, Nissim B, Hongkui D et al. Hallmarks of pluripotency. Nature 2015; 525: 469-478.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
11. Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K et al. The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res 2008; 10: R53.
12. Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI. The CD44+/CD24-phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol 2011; 28: 745-752.
13. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
14. Golebiewska A, Brons NH, Bjerkvig R, Niclou SP. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 2011; 8: 136-147.
15. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253-1270.
16. Tu LC, Foltz G, Lin E, Hood L, Tian Q. Targeting stem cells-clinical implications for cancer therapy. Curr Stem Cell Res Ther 2009; 4: 147-153.
17. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990; 10: 28-36.
18. Poirier F, Chan CT, Timmons PM, Robertson EJ, Evans MJ, Rigby PW. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991; 113: 1105-1114.
19. Venkatraman A, He XC, Thorvaldsen JL, Sugimura R, Perry JM, Tao Fe et al. Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence. Nature 2013; 500: 345-349.
20. Dey BK, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev 2014; 28: 491-501.
21. Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S et al. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene 2014; 34: 1-9.
22. Rachmilewitz J, Elkin M, Rosensaft J, Gelman-Kohan Z, Ariel I, Lustig O et al. H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene 1995; 11: 863-870.
23. Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg 2016; 124: 129-136.
24. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
25. Bazley FA, Liu CF, Yuan X, Hao H, All AH et al. Direct reprogramming of human primordial germ cells into induced pluripotent stem cells: efficient generation of genetically engineered germ cells. Stem Cells Dev 2015; 24: 2634-2648.
26. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, Rustgi AK. LIN28B promotes colon cancer progression and metastasis. Cancer Res 2011; 71: 4260-4268.
27. Viswanathan SR, Daley GQ. Lin28: a microRNA regulator with a macro role. Cell 2010; 140: 445-449.
28. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 2008; 32: 276-284.
29. Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009; 138: 696-708.
30. Zhou J, Ng SB, Chng WJ. LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. Int J Biochem Cell Biol 2013; 45: 973-978.
31. Büssing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008; 14: 400-409.
32. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
33. Tothova Z, Gilliland DG. A radical bailout strategy for cancer stem cells. Cell Stem Cell 2009; 4: 196-197.
34. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH et al. Large intergen non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010; 42: 1113-1117.
35. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006; 66: 5330-5337.
36. Bauderlique-Le Roy H, Vennin C, Brocqueville G, Spruyt N, Adriaenssens E, Bourette RP. Enrichment of human stem-like prostate cells with s-SHIP promoter activity uncovers a role in stemness for the long noncoding RNA H19. Stem Cells Dev 2015; 24: 1252-1262.
37. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002; 23: 1885-1895.
38. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011; 71: 6320-6326.
39. Du Z, Sun T, Hacis linroruleyman E, Fei T, Wang X, Brown M et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun 2016; 7: 10982.
40. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69-80.
41. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumor Biol 2014; 35: 9163-9169.
42. Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ, Lee HY et al. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res 2014; 42: 13799-13811.
43. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L et al. The imprinted H19 LncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-112.
44. Sun X, Liu J, Xu C, Tang SC, Ren H. The insights of Let-7 miRNAs in oncogenesis and stem cell potency. J Cell Mol Med 2016; 20: 1779-1788.
45. Patel Y, Shah N, Lee JS, Markoutsa E, Jie C, Liu S et al. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth. Oncotarget 2016; 7: 18295-18308.
46. Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X et al. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Cell Tissue Res 2014; 358: 763-778.
47. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009; 3: 1743-1748.
48. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
49. Qiu C, Ma Y, Qang J, Peng S, Huang Y. Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res 2010; 38: 1240-1248.
50. Iwasaki S, Kawamata T, Tomari Y. Drosophila argonaute1 and argonaute2 employ distinct mechanisms for translational repression. Mol Cell 2009; 34: 58-67.